Top of page
Main Content

Publications

2012

  • Sim, M., Khong, E., Hulse. Motivational Interviewing in Handbook of Behavioural Medicine. John Wiley & Sons. (In Press)

2011

  • Arendts, G., Sim, M., Johnston, S., Brightwell, R. (2011). Paramed home: A protocol for a randomised controlled trial of paramedic assessment and referral to access medical care at home. BMC Emerg Med, 11, 7.
  • Almeida, O., Alfonso, H., Pirkis, J., Kerse, N., Sim, M., Flicker, L., Snowdon, J., Draper, B., Byrne, G., Goldney, R., Lautenschlager, N., Stocks, N., Scazufca, M., Huisman, M., Araya, R., & Pfaff, J. (2011). A practical approach to assess depression risk and to guide risk reduction strategies in later life. International Psychogeriatrics, 23(2), 280-201.
  • Lambert, JC, Dallongeville, J, Ellis K, Schraen-Maschke, S, Lui, J, Laws S, Dumont J, Richard F, Cottel, D, Berr C, Ames D, Masters C, Rowe C, Szoeke C, Tzourio C, Dartigues JF, Amouyel P. Association of plasma Ab peptides with blood pressure in the elderly. PLoS One 2011 6 (4) e184536 1-6
  • Gupta VB, Laws SM, Villemagne VL, Ames D, Bush AL, Ellis KA, Lui JK, Masters C, Rowe CC, Szoeke C, Taddei K, Martins RN, the AIBL research group. “Plasma Apolipoprotein E and Alzheimer’s disease risk: the AIBL study of ageing” Neurology,  2011 (march 22) 76(12) 1091-8.
  • Sohrabi, HR.; Weinborn, M; Badcock, J; Bates, KA.; Clarnette R; Trivedi, D; Verdile, G; Sutton, T; Lenzo, NP.; Gandy,SE.; Martins RN, Letter to the Editor: Revising the definition of Alzheimer’s disease: a new lexicon Lancet Neurology (accepted, 11 February 2011)
  • Sittironarrit G, Ames D, Bush AI, Faux N, Flicker L, Foster J, Holmer S, Lautenschlager NT, Maruff P, Masters CL, Martins RN, Rowe CC, Szoeke C, Ellis KA, and the AIBL research group. “Effects of anticholinergic drugs on cognitive function in older Australians: results from the AIBL study” Dementia and Geriatric Disorders, in press
  • Ellis KA, Rowe CC, Szoeke C, Villemagne VL, Ames D, Chételat G, Martins RN, Masters CL, Fripp J, Acosta O, Raniga P, Bourgeat P, Salvado O. “Advances in structural and molecular neuroimaging in Alzheimer's disease” MJA, in press
  • McBride J, Szoeke EI, Good NM, Ames D, Martins R, Masters C, Maruff P, Rowe CC, Savage G, Ellis KA. “A web-based normative data tool for assessing cognitive performance in healthy older Australians” MJA, in press
  • Newman, M., Verdile, G., Martins, R.N. and Lardelli, M. (2011). Zebrafish as a tool in Alzheimer’s disease research. BBA- Molecular Basis of Disease, 1812(3):346-52.
  • Chételat G, Villemagne V, Pike KE, Ellis KA, Bourgeat P, Jones G, O’Keefe GJ, Salvado O, Szoeke C, Martins RN, Ames D, Masters CL, Rowe CC,; AIBL Research Group. “Independent contribution of temporal ß-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer’s disease” Brain (2011) Mar; 134(Pt3): 798-807 [EPub:2011 Feb 9]
  • Avdesh A, Wong, P, Martins RN, and Mathew T Martin-Iverson,2011. Memory function in a mouse genetic model of Alzheimers disease (In Press), Journal of Alzheimers disease (accepted 16 Feb, 2011)
  • Sim, M., Wain, T., Khong, E. (2011). Aggressive behaviour – prevention and management in the general practice environment. Australian Family Physician, 40(11), 866-872

2010

  • Continuing Professional Development module Sim, M., Khong, E., Deacon, J., and Quinlivan, T. (2010, March). Challenging consultations. Check program of selfassessment,456. South Melbourne: The Royal Australian College of General Practitioners. ISSN 0812-9630.
  • Almeida, O.P., Alfonson, H., Pirkis, J., Kerse, N., Sim, M., Flicker, L., Snowdon, J., Draper, B., Byrne, G., Goldney, R.,Lautenschlager, N.T., Stocks, N., Scazufca, M., Huisman, M., Araya, R., and Pfaff, J. (2010). A practical approach to assess depression risk and to guide risk reduction strategies in later life. International Psychogeriatrics, 1-12. doi:10.1017/S1041610210001870
  • Kajiwara Y, Franciosi S, Takahashi N, Krug L, Schmeidler J, Taddei K, Harouitunian V, Fried U, Ehrlich M, Martins RN, Gandy SE. Buxbaum JD.Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer’s disease.Molecular Neurodegeneration (2010) 5(1) 1-11.
  • Newman, M., Wilson, L., Camp, E., Verdile, G., Martins, R. and Lardelli, M. A zebrafish melanophore model of amyloid beta toxicity. Zebrafish (2010) Vol 7 (2), 155-159.
  • Sharman, MJ, Shui Guanghou, Fernandis AZ, Lim, WLF, Berger T, Hone E, Taddei K, Martins IJ, Ghiso J, Buzbaum JD, Gandy S, Wenk M, & Martins RN. Profiling Brain and Plasma Lipids in Human APOE e2 and e4 Knock-in Mice Using Electrospray Ionization Mass Spectrometry. Journal of Alzheimer’s Disease (2010) 105-111.
  • Sharman MJ, Morici M, Hone E, Berger T, Taddei K, Martins IJ, Lim WLF, Singh S, Wenk MR, ghiso J, Buxbaum JD Gandy SE, Martins RN, APOE genotype results in differential effects on the peripheral clearance of amyloid-beta 42 in APOE knock-in mice and knock-out mice.  Journal of Alzheimer’s Disease (2010) 403-409.
  • Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O’Keefe G, Price R., Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins RN, Masters CL, Ames D, Villemagne VL. Amyloid imaging result from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiology of Aging (2010) 31 1275-1283.
  • Frost S, Martins RN, Kanagasingam Y. "Ocular Biomarkers for Early Detection of Alzheimer's Disease".J Alzheimers Dis. 2010, Vol 22, No.1, pp 1-16.
  • Miklossy J, Qing, H. Radenovic A, Kis A, Vileno B, Laszlo F, Miller L.. Martins RN, Waeber G, Mooser V, Bosman F, Khalili K, Darbinian N & McGeer PL. Beta amyloud and hyperphosphorylated tau eposits in the pancreas in type 2 diabetes. Neurobiology of Aging (2010) 1503-151
  • Barron A, Verdile G, Taddei K, Bates KA, and Martins RN (2010) Effect of chronic hCG administration on Alzheimer’s – related cognition and Aβ accumulation in PSIKI mice. Endocrinology,  (2010) 151(11):5380-8.
  • Taddei K, Laws SM, Verdile G, Munns S, D’Costa K, Harvey AR, Martins IJ, Hill F, Levy C, Shaw JE. & Martins RN. Novel phage peptides attenuate beta amyloid-42 catalysed hydrogen peroxide production and associated neurotxicity. Neurobiology of Aging (2010) 31(2)203-214.
  • Jenner AM, Lim WLF, Ng, MPE, Wenk MR, Shui G, Sharman MJ, Gandy SE & Martins RN, The effect of APOE genotype on brain levels of oxysterols in young and old humans APOE e2 e3 and e4 knock-in mice. Neuroscience (2010) 169 109-115.
  • Rodrigues MA, Foster JK, Verdile G, Joesbury K, Prince R, Devine A. Mehta P, Beilby J. Martins RN. Predicting memory decline as a risk factor for Alzheimer’s disease in older post-menopausal women: quod erat demonstrandum? Int. Psychogeratr. (2010) Mar: 22(2) 332-5.
  • Lui JK*, Laws SM*, Qiao-Xin Li, Villemagne V, Ames D, Brown B, Bush AI, DeRuyck K, Dromey J, Ellis KA, Faux NG, Foster J, Fowler C, Gupta V, Hudson P, Laughton K, Masters CL, Pertile K, Rembach A, Rimajova M, Rodrigues M, Rowe C, Rumble R, Szoeke C, Taddei K, Taddei T, Trounsen B, Ward, V, Martins RN. Plasma amyloid beta as a biomarker in Alzheimer’s disease: The AIBL Study of Ageing. Journal of Alzheimer’s Disease  EPub ahead of print April 22, (2010) 20(4) 1233-1242.* Contributed equally.
  • Ellis KA, Rowe CC, Villemagne VL, Martins RN, Masters CL, Salvado O, Szoeke C, Ames D, the AIBL research group. “Addressing population aging and Alzheimer’s disease through the Australian Imaging Biomarkers and Lifestyle study: Collaboration with the Alzheimer ’s disease Neuroimaging Initiative” Alzheimer’s and Dementia 2010. 6(3): 291-296 [doi: 10.1016/j.jalz.2010.03.009]
  • Bharadwaj P, Martins R, Macreadie I. Yeast as a model for studying Alzheimer's disease. FEMS Yeast Res. 2010 Dec;10(8):961-9. doi:10.1111/j.1567-1364.2010.00658.x. Review. PubMed PMID: 20618869. 
  • Bourgeat P, Chetelat G, Villemagne VL, Fripp J, Raniga P, Acosta O, Szoeke C, Ourselin S, Ames D, Ellis KA, Martins RN, Masters CL, Rowe CC, Salvado O and the AIBL Research Group. Aβ burden in the temporal neocortex is related to hippocampal atrophy in non-demented elderly. Neurology 2010 74(2) 121-7 PubMed PMID 2006524.
  • Lau S, Bates KA, Sohrabi HR, Rodrigues M, Martins G, Dhaliwal SS, Taddei K, Laws SM, Martins IJ, Mastaglia FL, Foster JK, Phillips JK, Martins RN. Functional effects of genetic polymorphism in inflammatory genes in subjective memory complainers. Neurobiol Aging. 2010 Oct 18. [Epub ahead of print] PubMed PMID:20961668. doi:10.1016/j.Neurobiol Aging.2010.09.003
  • Chetelat G, Villemagne VL, Bourgeat P, Pike KE, Jones G, Ames D, Ellis KA,Szoeke C, Martins RN, O'Keefe GJ, Salvado O, Masters CL, Rowe CC; Australian Imaging Biomarkers and Lifestyle Research Group. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Ann Neurol. 2010 Mar;67(3):317-24.PubMed PMID: 20373343.
  • Peiffer JJ, Galvao DA, Gobbs Z, Smith K, Turner D, Foster J, Martins R, Newton RU. Strength and functional characteristics of men and women 65 years and older. Rejuvenation Res. 2010 13(1) 75-82.
  • Chételat G, Villemagne V, Pike KE, Baron JC, Bourgeat P, Jones G, Faux NG, Ellis KA, Salvado O, Szoeke C, Martins R, Ames D, Masters CL, Rowe CC, and the AIBL Research Group. “Larger temporal volume in elderly with high versus low beta-amyloid deposition” Brain 2010 November; 133(11): 3349-58 [Epub: 2010 August 25] [doi:10.10193/brain/awq187]

2009

  • Wilkinson, A. M., and Sim, M. (2009). Encyclopedia of the life course and human development (pp. 134-137) Book: End of life decision making. In D. Carr (Ed.),. Detroit: MacMillan Reference USA.
  • Pfaff, J. J., Draper, B. M., Pirkis, J. E., Stocks, J. A., Snowden, J. A., Sim, M. G., Byrne, G. J., Lautenschlager, N. T., Flicker, L. A., Kerse, N. M., Goldney, R. D., and Almeida, O. P. Medical morbidity and severity of depression in a large primary care sample of older Australians: the DEPS-GP project. Journal: Medical Journal of Australia (in press).
  • Sim, M., Wain, T. and Khong, E. (2009, in press). Influencing behaviour change in general practice (Part 1): Brief intervention and motivational interviewing Australian Family Physician
  • Sim, M., Wain, T. and Khong, E. (2009, in press). Influencing behaviour change in general practice (Part 2): Motivational interviewing approaches. Australian Family Physician
  • Sim, M., Wain, T. and Khong, E. Influencing behaviour change in general practice (Part 1): Brief intervention and motivational interviewing Australian Family Physician; 38(11): 885-888
  • Sim, M., Wain, T. and Khong, E. Influencing behaviour change in general practice (Part 2): Motivational interviewing approaches. Australian Family Physician; 38(12): 986-989.
  • Continuing Professional Development module
    Sim, M., Khong, E., and Wain, T. (2009, October). Motivational interviewing in general practice. Check program of self-assessment, 451. South Melbourne: The Royal Australian College of General Practitioners. ISSN 0812-9630.
  • Foster JK, Verdile G, Bates KA, Martins RN, Immunization in Alzheimer’s disease: naïve hope or realistic clinical potential? Molecular Psychiatry (2009) 14:239-251
  • De Silva R, Disanayak S, De Zoysa N, Sanjeewanie N, Somaratne S, Foster JK, Srikanth S, Katriarachchi, S, Martins R. Prevalence of cognitive impairment in elders’ homes in Sri Lanka. International Journal of Geriatric Psychiatry. (2008) (Accepted October)
  • Sohrabi HR, Bates KA, Rodrigues M. Taddei K, Martins G, Laws SM, Lautenschlager NT, Dhaliwal SS, Foster JK, Martins RN, The relationship between memory complaints, perceived quality of life and mental health in apolipoprotein Ee4 carriers and non-carriers Journal of Alzheimer’s disease, (2009) 17(1):69-79.
  • Bharadwaj PR, Dubey AK, Masters CL, Martins RN, Macreadie IA. Aβ aggregation and possible implication in Alzheimer’s disease pathogenesis. Journal of Cellular and Molecular Medicine. (2009) 13(3)412-21
  • Bates KA, Verdile G. Q-X Li, Ames D, Hudson P, Masters CL and Martins RN. Clearance mechanisms of Alzheimer’s amyloid-β peptide: implications for therapeutic design and diagnostic tests. Feature Review Molecular Psychiatry (2009) 14:469-486.
  • Barron A.M., Cake M., Verdile G., and Martins RN. Ovariectomy and 17b-estradiol replacement do not alter beta amyloid levels in sheep brain.Endocrinology, (2009) 150(7):3228-36
  • Chen M. Martinas RN Lardellie M. Complex splicing and neural expression of duplicated tau genes in Zebrafish embryos. Journal of Alzheimer’s Disease. (2009) 18(2)305-17.
  • Sohrabi HR, Bates KA, Rodrigues M, Taddei K, Laws SM, Lautenschlager NT, Dhaliwal SS, Johnston ANB, Mackay-Sim A, Foster JK, Martins RN. Olfactory dysfunction is associated with subjective memory complaints in community-dwelling elderly individuals. Journal of Alzheimer’s Disease (2009) 17(1): 135-42.
  • De Silva R, Disanayaka S, De Zoysa N, Sanjeewanie N, Somaratne S, Foster JK, Srikanth S, Katriarachchi ST, Martins RN. Norms for the mini-mental state examination from a sample of Sri Lankan older people. Int.J. Geriatr Psychiatry (2009) 24(7) 666-670.
  • Pedrini S, Thomas C, Brautigam H, Schmeidler J, Ho Lap, Fraswer P, Westaway D, Hyslop P StG, Martins RN, Buxbaum JD, Pasinetti GM, Dicksterin DL, Hof PR, Ehrlich ME, Gandy S. Dietary composition modulates brain mass and solubilizable A levels in a mouse model of aggressive Alsheimer’s amyloid pathology. Molecular Neurodegenration (2009) 4(40)1-10.
  • Bates K, Hamid R, Sohrabi H, Rodrigues M, Beilby J, Dhaliwal SS, Taddei K, Criddle A, Wraith M, Howard M, Martins G, Paton A, Mehta P, Foster JK, Martins IJ, Lautenschlager N. Mastaglia F, Laws S, Gandy SE, & Martins RN. Association of Cardiovascular Factors & Alzheimer’s Disease Plasma Amyloid-β Protein in Subjective Memory Complainers. Journal of Alzheimer’s Disease  (2009) 17(2):305-18 Mar 56 E-Pub ahead of print.
  • Nornes S, Newman M, Wells S, Verdile G, Martins RN & Lardelli M. Independent and co-operative action of Psen2 with Psen1 in Zebrafish embryos. Exp. Cell Res (2009) 315(16): 2791-801 Accepted June 26 (Epub ahead of print)
  • Ellis KA, Bush AI,Darby D, De Fazio D, Foster J, Hudson P, Lauatenschlager NT, Lenzo N, Martins RN, Maruff P, Masters C, Milner A, Pike Rowe, Savage G, Szoeke C, Taddei K, Villemagne V, Woodward M, Ames D: The AIBL Research Group. The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer’s disease INT Psychogeriatr. 2009 May 27:1-16 (Epub ahead of print). ( 2009) 21:627-687.
  • Drummond ES, Harvey AR, Martins RN. Curr Opin Endocrinol Diabetes Obes. (2009) June 16 (3): 254-9 Review.
  • Martins IJ, Berger T, Sharman MJ, Verdile G, Fuller SJ and Martins RN; Cholesterol Metabolism and Transport in the Pathogenesis of Alzheimers disease, Journal of Neurochemistry, (2009) 111(6) 1275-308
  • Sudarsan Krishnaswamy, Verdile G, Groth D, Kaneyenda L and Martins RN; The structure and function of Alzheimers gamma secretase enzyme complex, Critical Reviews in Clinical Laboratory Sciences, 2009 46(5-6):282-301.
  • Hata S. Fujishige S. Araki Y. Kato N. Araseki M. Nishimura M. Hatmann D, Saftig P, Fahrenholz, F, Taniguchi M, Katsuya U, Akatsu H, Martins RN, Yamamoto K, Maeda M, Yamamoto T, Nakaya T, Gandy S, Suzuki T. Alcadein cleavages by amyloid B-Precursor Protein (APP) α- and γ-Secretases generate small peptides, p3-Alcs, indicating Alzheimer’s disease-related γ-secretase dysfunction. Journal of Biological Chemistry. (2009) 284 (52), 36024-36033.

2008

  • Shuttleworth, C., Rudd, C. J., Smith, P., Combs, S. and Wain, T. (in press), The experience of faculty practice: Developing and evaluating a newly established program, Nurse Education Today.
  • Sim, M (2007). Using Motivational Interviewing in primary care, The Chronicle, Publication of the Chronic Diseases Network, 10 (4), 2007
  • Almeida, O.P., Pfaff, J., Tyson, O., Pirkis, J., Flicker, L., Lautenschlager, N., Sim, M., Draper, B., Snowdon, J., Goldney, R., Byrne, G., Stocks, N., Wilson, I., and Kerse, N. (2007). No more depression! Can we really prevent depression in later life? Australian and New Zealand Journal of Psychiatry, 41(Supp 2), A192.
  • Sim, M., Khong, E., and Jiwa, M. (In press, accepted 7 January 2008). Does general practice Google? Australian Family Physician.
  • Wilkinson, A. and Sim, M. (2009). Decision-Making at the End-of-Life. Encyclopedia of the Life Course and Human Development, Gale Publishing, part of Cengage Learning, Framing Hills, MI.
  • Kerse, N., Flicker, L., Pfaff, J.J., Draper’ Lautenschlager, N.T., Sim, M., Snowden, J. and Almeide, O.P. (2008).
  • Shuttleworth, C, Rudd, CJ, Smith, P, Combs, S and Wain, TD. (2008). The experience of faculty practice: Developing and evaluating a newly established program Nurse Education Today (in press, August publication).
  • Sim, M., Cheng, W., Dore, G., and Beers, K. (2008).Signs and symptoms of chronic hepatitis C. In Bradford, D., Dore, G., Grulich, A., Kidd, M., Hoy, J., McCoy, R., Matthews, G., Milch, A., and Strasser, S. (Eds.) (2008), HIV, viral hepatitis and STIs: A guide for primary care (Ch. 7, 71-79). Darlinghurst, NSW: Australian Society for HIV Medicine. ISBN 978-1-920773-50-2.
  • Khong, E. and Sim, M. Benzodiazepine dependence: an update on management for BMJ Learning website. May 2008
  • McConigley, R., Toye, C., Goucke, R., and Kristjanson, L. J. (2008). Developing Recommendations for Implementing the Australian Pain Society’s Pain Management Strategies in Residential Aged Care. Australasian Journal on Ageing, 27, (1), 45-49.
  • Wilkinson, A. and Sim, M. (in press). Decision-Making at the End-of-Life. Encyclopedia of the Life Course and Human Development, Gale Publishing, part of Cengage Learning, Framing Hills, MI.
  • Lorenz, K., Lynn, J., Dy, S., Shugarman, L.R., Wilkinson, A.M., Mularski, R.A., Morton, S.C., Hughes, R., Hilton, L.K., Maglione, M., Rhodes, S.L., Rolon, C., Sun, V.C. and Shekelle, P.G. The Evidence for Improving Care at the End of Life: A Systematic Review. Published as Qaseem A., Snow V., Shekelle P. et al. (2008). Evidence-Based Interventions to Improve the Palliative Care of Pain, Dyspnea, and Depression at the End-of-Life: A Clinical Practice Guideline from the American College of Physicians. Annals of Internal Medicine, 148:141-146.
  • Shuttleworth, C., Rudd, C.J., Smith, P., Combs, S. and Wain, T.D. (2008) The experience of faculty practice: Developing and evaluating a newly established program. Nurse Education Today, 28, 702-710.
  • Sim, M., Khong, E., and Jiwa, M. (2008).Does general practice Google? Australian Family Physician, 37(6), 471-474.
  • Khong, E., and Sim, M. (2008).Benzodiazepine dependence: an update on management. BMJ Learning. ISSN 1752-8526.
  • Sim, M., Cheng, W., Dore, G., and Beers, K. (2008).Signs and symptoms of chronic hepatitis C. Book: In Bradford, D., Dore, G., Grulich, A., Kidd, M., Hoy, J., McCoy, R., Matthews, G., Milch, A., & Strasser, S. (Eds.) (2008), HIV, viral hepatitis and STIs: A guide for primary care (Ch. 7, 71-79). Darlinghurst, NSW: Australian Society for HIV Medicine. ISBN 978-1-920773-50-2.
  • Nornes S, Newman M., Verdile G, Wells S., Stoick-Cooper C, Tucker B., Friedrich-Sleptsova I, Martins RN and Lardelli M. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. Human Molecular Genetics, 2008 17:402-412 (E Pub 2007)
  • Rodrigues, M.A., Verdile G., Foster J.K., Hogervorst E., Joesbury K., Dhaliwal S., Corder E.H, Laws, S.M., Hone E., Prince, R., Devine A., Mehta, P., Beilby J., Atwood C.S., Martins, R.N.Gonadotropins and Cognition in Older Women. Journal of Alzheimer’s Disease. (2008) 13(3) 267-274.
  • Hsien W.Chan, Tianbing Liu, Giuseppe Verdile, Glenda Bishop, Ryan J Haasl, Mark A Smith, George Perry, Ralph N Martins and Craig S Atwood. Copper Induces Apoptosis of Neuroblastoma Cells via Post-translatinal Regulation of the Expression of Bcl-2-family Proteins and the txj Mouse is a better Model of Hepatic than Brain Cu Toxicity. Int J Clin Exp Med (2008) 1:76-88.
  • Rimajova M., Lenzo NP., Wu JS, Bates KA, Campbell A., Dhaliwal SS, McCarthy M. Rodrigues M., Paton A, Rowe C, Foster JK., Martins RN. Fluoro-2-deoxy-D-glucose (FDG)-PET in APOE epsilon 4 carriers in the Australian population. Journal of Alzheimer’s Disease (2008) Vol 13:(2) 137-146
  • Flicker L, Martins RN, Thomas J, Acres J, Taddei K, Vasikaran SD, Norman P, Jamrozik K, Almeida OP. B-vitamins reduce plasma levels of beta amyloid. Neurobiology of Aging (2008) 29:303-305.
  • Verdile G., Yeap B.B., Clarnette R.M., Dhaliwal S., Burkhardt M.S., Chubb S.A.P., De Ruyck K., Rodrigues M., Metha D. P., Foster J.K., Bruce, D.G. and Martins R.N. (2008). Luteinizing hormone are positively correlated with plasma amyloid-b-protein levels in elderly men. Journal of Alzheimer’s Disease.(2008) 14(2)201-208
  • Miklossy J and Martins RN. Chronic Inflammation and Amyloidgenesis in Alzheimer’s Disease: The emerging Role of Infection. Journal of Alzheimer’s Disease. (2008) 13(4) 357.
  • Urosevic N. and Martins RN. Infection and Alzheimer’s Disease: The APOE ε4 Connection and Lipid Metabolism. Journal of Alzheimer’s Disease. (2008) 13 (4) 421-435.
  • Gnjec A, D’Costa K, Laws SM, Hedley R, Balakrishan K. Martins G, Paton A, Verdile G, Gandy SE, Broe GA, Brooks WS, Bennett H, Piguet O, Price P, Miklossy J, Hallmayer J, McGeer PL. Martins RN Association of alleles carried at TNFA -850 and BATI -22 with Alzheimer’s disease. Journal of Neuroinflammation (2008) 5:36
  • Wahjoepramono EJ, Wijaya LK, Taddei K, Martins G. Howard M, de Ruyck K, Bates K, Dhaliwal SS, Verdile G, Carruthers M, Martins RN. Distinct effects of testosterone on plasma and cerebrospinal fluid amyloid-β levels. Journal of Alzheimer’s Disease. (2008) 15(1)129-137.
  • Maczurek A, Hager K, Kenklies M, Sharman M, Martins RN, Engel J, Carlson DA, Munch G. Lipoic acid as an anti-inflammatory and neuroprotective treatment for Alzheimer’s disease. Advanced Drug Delivery Reviews (2008) 60:1463-1470.
  • Barron, A.M., Taddei, K., Verdile, G. & Martins, R.N. Time and dose dependent effects of human chorionic gonadotropin on APP processing and beta amyloid levels in the PS1M146V mouse model of Alzheimers disease. Alzheimer's and Dementia. 2008 4(4) S1:T347
  • Foster JK, Sohrabi HR, Verdile G, Martins RN. Research criteria for the diagnosis of Alzheimer’s disease: genetic risk factors, blood biomarkers and olfactory dysfunction. International Psychogeriatrics. (2008) 20(4):253-255
  • Barron AM., Verdile G. and Martins RN (2008). The Role of Luteinizing Hormone in Alzheimers Disease. In Gonadal and nongonadal actions of Gonadotropins pp 275-290. Narosa Publishing House Pvt. Ltd, Dehli, India.
  • Verdile G and Martins RN. The role of gonadotropins and testosterone in the regulation of beta amyloid metabolism. In Hogervorst, Henderson, Gibbs & Brinton (Eds.), Hormones, Cognition and Dementia: State of the Art and Emergent Therapeutic Strategies. Cambridge University Press, Shaftesbury Road, Cambridge CB2 8RU, UK, 2008 in press
  • Verdile GandMartins RN (2008). Molecular Genetics of Alzheimers Disease. In Wildenauer D (ed) Molecular Biology of Neuropsychiatric Disorders pp 231-278. Springer-Verlag, Berlin Heidelberg.

2007

  • Miklossy J, Kis A, Radenovic A, Miller L, Forro L, Martins RN, Reiss K, Darbvinian N, Darekar P, Mihaly L, Khalili K. Beta-amyloid deposition and Alzheimer’s type changes induced by Correlia spirochetes. Neurobiology of Aging 2006) 27: 228-236.
  • Butterfield, DA, Gnjec A, Poon HF, Castegna A, Pierce WM, Klein JB, Martins RN. Redox proteomics identification of oxidatively modified brain proteins in inherited Alzheimer’s disease: An Initial assessment. J Alzheimer’s Disease. 2006 10(4):391-7.
  • Bates KA, Martins RN, and Harvey AR. Oxidative stress in a rat model of chronic gliosis. Neurobiol Aging. 2007 Jul;28(7):995-1008. Epub 2006 Jun 23.
  • McRae A, Martins RN, Fonte J, Kraftsik R, Hirt L, Miklossy J. Cerebrospinal fluid antimicroglial antibodies in Alzheimer disease: A putative marker of an ongoing inflammatory process. Exp. Gerontology (2007) 42:355-363
  • Verdile G, Gandy SE, Martins RN. The role of presenilin and its interacting proteins in the biogenesis of Alzheimer's beta amyloid. Neurochem Res. 2007 Apr-May;32(4-5):609-23. Epub 2006 Aug 31. Review. PMID: 16944319
  • Fuller SJ., Tan RS. Martins RN. Androgens in the Etiology of Alzheimer’s Disease in Aging Men and Possible Therapeutic Interventions.. Journal of Alzheimer’s Disease (2007) 12(2)129-142.

2006

  • Crochley, K., Wylie, E. and Khong, E., (2006). Hormone replacement therapy and mammographic screening outcomes in Western Australia, Journal of Medical Screening, 13(2):93-97.
  • Hulse, G., Sim, M. and Khong, E., (2006). Acute pain: the management of opioid seeking behaviour, Helix Review Series – Neuropathic Pain, 1/2006.
  • Sim, M. and Khong, E., (2006). Prevention: Building on routine clinical practice, Australian Family Physician, 35(1/2):12-15.
  • Barron A, Verdile G and Martins RN. Gonadotropins: potential targets for preventative and therapeutic interventions in Alzheimer’s disease. Future Medicine (2006) 1(2) 189-202.
  • Martins IJ, Hone E, Foster J, Sünram-Lea S, Gnjec A, Fuller SJ, Nolan D, Gandy, SE and Martins RN. Apolipoprotein E, cholesterol metabolism, diabetes, and the convergence of risk factors for Alzheimer’s disease and cardiovascular disease. Molecular Psychiatry (2006) 11, 721-736.
  • Barron AM, Verdile G. and Martins RN. The role of gonadotropins in Alzheimer’s disease: potential neurodegenerative mechanisms. Endocrine (2006) (2):257-70.
  • Burkhardt MS, Foster JK, Clarnette RM, Chub SAP, Bruce DG, Drummond PD, Martins RN and Yeap BB. Interaction between Testosterone and Apolipoprotein E e4 Status on Cognition in Healthy Older Men.The Journal of Endocrinology & Metabolism. (2006) 91(3):1168-1172.
  • House MJ, St Pierre TG, Foster JK, Martins RN, Clarnette R. Quantitative MR imagining R2 relaxometry in elderly participants reporting memory loss. American Journal Neuroradiology. (2006) (2):430-9.
  • Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kolsch H, Laws SM, Klopp N, Bickeboller H, Wagenpfeil S, Mueller J, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Muller U, Illig T, Heun R, Egensperger R, Schlegel J, Forstl H, Martins RN, Geman Sib-Pair Study Group, Kurz A. A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer’s disease. Human Molecular Genetics (2006) (15) 2446-2456.
  • Barron AM, Fuller SJ, Verdile G, Martins RN. Reproductive hormones modulate oxidative Stress in Alzheimer’s disease. Antioxid. Redox signal. (2006) Nov 8(11-12):2047-2059
  • Pickering-Brown SM, Baker M, Gass J, Boeve BF, Loy CT, Brooks WS, Mackenzie IRA, Martins RN, Krok JBJ, Halliday GM, Kril J, Schofield PR, Mann DMA, Hutton M. Mutations in progranulin ecxplain atypical phenotyres with variants in MAPT. Brain (2006) 129: 3124-3126.
Skip to top of page